This list is an analysis based on recent market events. It's not an investment recommendation.
About
Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. Its core product is EAL, a multi-target cellular immunotherapy product that is in Phase II clinical trials for the prevention of postsurgical recurrence of liver cancer. The company is also conducting pre-clinical and clinical trial studies for EAL to treat lung cancer, glioma, gastric cancer, and colorectal cancer. In addition, it develops 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; CAR-T-19 injection product for B-cell acute lymphoblastic leukaemia; and TCR-T cell series products to treat solid tumors. The company was founded in 2006 and is headquartered in Beijing, the People's Republic of China.
The current price of 6978.HK is HK$1.06 HKD — it has decreased by -5.36% in the past 24 hours. Watch Immunotech Biopharm stock price performance more closely on the chart.
What is Immunotech Biopharm stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Immunotech Biopharm stocks are traded under the ticker 6978.HK.
Is Immunotech Biopharm stock price growing?▼
6978.HK stock has fallen by -53.51% compared to the previous week, the month change is a -61.03% fall, over the last year Immunotech Biopharm has showed a -73.16% decrease.
What is Immunotech Biopharm market cap?▼
Today Immunotech Biopharm has the market capitalization of 308.52M
When is the next Immunotech Biopharm earnings date?▼
Immunotech Biopharm is going to release the next earnings report on August 21, 2026.
What is Immunotech Biopharm revenue for the last year?▼
Immunotech Biopharm revenue for the last year amounts to 96.49M HKD.
What is Immunotech Biopharm net income for the last year?▼
6978.HK net income for the last year is -1.07M HKD.
How many employees does Immunotech Biopharm have?▼
As of May 05, 2026, the company has 268 employees.
In which sector is Immunotech Biopharm located?▼
Immunotech Biopharm operates in the Health & Wellness sector.
When did Immunotech Biopharm complete a stock split?▼
Immunotech Biopharm has not had any recent stock splits.
Where is Immunotech Biopharm headquartered?▼
Immunotech Biopharm is headquartered in Beijing, Hong Kong.